149 related articles for article (PubMed ID: 10496655)
21. Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Evaluation of the topical and systemic anti-inflammatory activity in the rat.
Calpena AC; Escribano E; San Martin H; Lauroba J; Obach R; Domenech J
Arzneimittelforschung; 1999 Dec; 49(12):1012-7. PubMed ID: 10635447
[TBL] [Abstract][Full Text] [Related]
22. Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition.
Yoshida D; Todo H; Hasegawa T; Sugibayashi K
Int J Pharm; 2007 Jun; 337(1-2):142-7. PubMed ID: 17280809
[TBL] [Abstract][Full Text] [Related]
23. Drug targeting efficacy to underlying muscle following topical application. I. Evaluation based on a physiological pharmacokinetic model.
Hatanaka T; Manabe E; Ohtsuki T; Okuyama K; Mori M; Okada H; Katayama K; Koizumi T
Biol Pharm Bull; 2000 Jul; 23(7):860-5. PubMed ID: 10919367
[TBL] [Abstract][Full Text] [Related]
24. Transplacental pharmacokinetics of diclofenac in perfused human placenta.
Shintaku K; Hori S; Tsujimoto M; Nagata H; Satoh S; Tsukimori K; Nakano H; Fujii T; Taketani Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2009 May; 37(5):962-8. PubMed ID: 19204082
[TBL] [Abstract][Full Text] [Related]
25. Subcutaneous concentrations following topical iontophoretic delivery of diclofenac.
Kasha PC; Anderson CR; Morris RL; Sembrowich WL; Chaturvedula A; Banga AK
Drug Discov Ther; 2012 Oct; 6(5):256-62. PubMed ID: 23229146
[TBL] [Abstract][Full Text] [Related]
26. Diclofenac metabolic profile following in vitro percutaneous absorption through viable human skin.
Tanojo H; Wester RC; Shainhouse JZ; Maibach HI
Eur J Drug Metab Pharmacokinet; 1999; 24(4):345-51. PubMed ID: 10892898
[TBL] [Abstract][Full Text] [Related]
27. Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application.
Cross SE; Megwa SA; Benson HA; Roberts MS
Pharm Res; 1999 Mar; 16(3):427-33. PubMed ID: 10213375
[TBL] [Abstract][Full Text] [Related]
28. In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers.
Hui X; Hewitt PG; Poblete N; Maibach HI; Shainhouse JZ; Wester RC
Pharm Res; 1998 Oct; 15(10):1589-95. PubMed ID: 9794502
[TBL] [Abstract][Full Text] [Related]
29. Diclofenac concentrations in defined tissue layers after topical administration.
Müller M; Mascher H; Kikuta C; Schäfer S; Brunner M; Dorner G; Eichler HG
Clin Pharmacol Ther; 1997 Sep; 62(3):293-9. PubMed ID: 9333105
[TBL] [Abstract][Full Text] [Related]
30. Deep tissue penetration of bases and steroids after dermal application in rat.
Singh P; Roberts MS
J Pharm Pharmacol; 1994 Dec; 46(12):956-64. PubMed ID: 7714719
[TBL] [Abstract][Full Text] [Related]
31. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes.
Cevc G; Blume G
Biochim Biophys Acta; 2001 Oct; 1514(2):191-205. PubMed ID: 11557020
[TBL] [Abstract][Full Text] [Related]
32. Biodistribution of diclofenac following repeated topical applications of two diclofenac sodium formulations to minipigs.
Wible JH; Barrett T; Devarakonda K; Giuliani M
Biopharm Drug Dispos; 2014 Mar; 35(2):87-96. PubMed ID: 24122676
[TBL] [Abstract][Full Text] [Related]
33. Effect of lecithin on epicutaneous absorption of diclofenac epolamine.
Conte A; Ronca G; Petrini M; Mautone G
Drugs Exp Clin Res; 2002; 28(6):249-55. PubMed ID: 12776579
[TBL] [Abstract][Full Text] [Related]
34. Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer.
Higaki K; Asai M; Suyama T; Nakayama K; Ogawara K; Kimura T
Int J Pharm; 2002 Jun; 239(1-2):129-41. PubMed ID: 12052698
[TBL] [Abstract][Full Text] [Related]
35. Estimation of intradermal disposition kinetics of drugs: I. Analysis by compartment model with contralateral tissues.
Nakayama K; Matsuura H; Asai M; Ogawara K; Higaki K; Kimura T
Pharm Res; 1999 Feb; 16(2):302-8. PubMed ID: 10100318
[TBL] [Abstract][Full Text] [Related]
36. Topical skin penetration of diclofenac after single- and multiple-dose application.
Dehghanyar P; Mayer BX; Namiranian K; Mascher H; Müller M; Brunner M
Int J Clin Pharmacol Ther; 2004 Jul; 42(7):353-9. PubMed ID: 15605686
[TBL] [Abstract][Full Text] [Related]
37. Analysis of skin disposition of flurbiprofen after topical application using dual agar gel discs-inserted rats.
Hasegawa T; Kawazome A; Yanagimoto G; Hayashi T; Seki T; Akimoto M; Todo H; Sugibayashi K
Biol Pharm Bull; 2007 Nov; 30(11):2135-40. PubMed ID: 17978488
[TBL] [Abstract][Full Text] [Related]
38. Bioequivalence of diclofenac sodium 2% and 1.5% topical solutions relative to oral diclofenac sodium in healthy volunteers.
Holt RJ; Taiwo T; Kent JD
Postgrad Med; 2015 Aug; 127(6):581-90. PubMed ID: 26077436
[TBL] [Abstract][Full Text] [Related]
39. Biopharmaceutical and pharmacodynamic studies on topically applied diclofenac gel available in Indian market.
Bhaskar K; Ramachandran S; Sridhar SK; Rajarajan AT; Ramkumar A; Sanathkumar K; Srinivasa Rao G; Anbu J; Dhanaraju MD; Saravanan M
Boll Chim Farm; 2004 Jun; 143(5):208-10. PubMed ID: 15360107
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin.
Higaki K; Nakayama K; Suyama T; Amnuaikit C; Ogawara K; Kimura T
Int J Pharm; 2005 Jan; 288(2):227-33. PubMed ID: 15620862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
